Colgate-Palmolive records higher Q3 sales as revenue reaches $5.37 billion
Key points
- Colgate-Palmolive (NYSE:CL) reported third-quarter 2026 net sales of $5.37 billion, up 4.6% year over year.
- Adjusted EPS reached $0.97, beating analyst expectations of approximately $0.92–$0.93, while GAAP net income increased to $751 million.
- The company narrowed its full-year sales growth guidance to 4%–5% and raised its outlook for base business EPS and gross profit margins.
Colgate-Palmolive (NYSE:CL) reported third-quarter 2026 net sales of $5.37 billion, up 4.6% year over year, while adjusted earnings per share reached $0.97, exceeding analyst expectations.
Revenue surpassed the approximately $5.34 billion analyst estimate, while GAAP diluted EPS increased 3% to $0.94 from $0.91 in the third quarter of 2025.
The company reported that global organic sales increased 3.6%, with volume growth improving for the fourth consecutive quarter.
GAAP net income attributable to Colgate-Palmolive increased to $751 million from $735 million a year earlier, while GAAP gross profit margin expanded 80 basis points to 60.2%.
The company narrowed its full-year 2026 net sales growth outlook to 4%–5% and raised its expectations for full-year base business earnings per share and gross profit margins.
Meanwhile, Colgate-Palmolive's adjusted EPS of $0.97 exceeded the analyst consensus of approximately $0.92–$0.93.
Colgate-Palmolive operates across oral care, personal care, home care and pet nutrition markets, with brands including Colgate, Palmolive, Ajax, Hill's Science Diet and other consumer products.
Frequently asked questions
More from United States
Exelon Q3 revenue swings 9.2% to $7.32 billion
General Dynamics delivers 12.9% revenue growth to $14.6 billion in Q3
LyondellBasell Q3 profit comes in at $758 million as revenue rises
Kenvue reports 3.2% Q3 sales growth, EPS up 5%
Newell Brands posts 3.7% Q3 sales growth
TXNM Q3 net earnings revs to $163.4 million
